This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

India's DABUS copyright test may not work for everyday AI users

By Freny Patel ( September 8, 2026, 03:48 GMT | Comment) -- India’s Copyright Office identified the human author for artwork generated by Stephen Thaler's DABUS-artificial intelligence system, but doing so for outputs produced through commercial generative-AI tools may prove harder. The ruling offers a route to copyright when a person controls the inputs and creative process, but less certainty when human involvement is limited to prompting, selecting or editing.India’s ruling on an artwork generated by Stephen Thaler’s DABUS artificial-intelligence system offers a workable route to copyright because Thaler’s unusually extensive involvement made him relatively easy to identify as the person behind the work. But it leaves businesses using third-party generative-AI tools without a clear answer to the commercially important question: When do prompting, selection and editing amount to authorship?...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login